Our study found that PTGDS and MYH9 inhibition decreased both the mRNA (Fig. 6G) and protein levels of STAT3 in DLBCL cells (Fig. 6A, B, Supplementary Fig. S6A–C, and E), indicating the interruption of the transcriptional process. The gene discussed is MYH9; the disease is diffuse large B-cell lymphoma.